A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs Response

被引：0
|
作者：
Papamichael, Konstantinos [1 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 12期
关键词：
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INFLIXIMAB; IBD;
D O I：
10.1038/ajg.2017.375
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1893 / 1894
页数：2
相关论文
共 50 条
  • [1] A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs
    Reinink, Andrew R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (12): : 1892 - 1893
  • [2] Therapeutic drug monitoring of anti-TNFα drugs in a UK tertiary IBD unit
    Barrow, V.
    Innes, A.
    Thompson, N.
    Mansfield, J.
    Speight, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S416 - S417
  • [3] Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
    Franca, Raffaella
    Curci, Debora
    Lucafo, Marianna
    Decorti, Giuliana
    Stocco, Gabriele
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (07) : 527 - 539
  • [4] Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
    Charabaty, Aline
    CROHNS & COLITIS 360, 2020, 2 (01)
  • [5] Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
    Wright, Emily K.
    Kamm, Michael A.
    De Cruz, Peter
    Hamilton, Amy L.
    Selvaraj, Fabiyola
    Princen, Fred
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Jakobovits, Simon L.
    Florin, Timothy H.
    Gibson, Peter R.
    Debinski, Henry
    Macrae, Finlay A.
    Samuel, Douglas
    Kronborg, Ian
    Radford-Smith, Graham
    Gearry, Richard B.
    Selby, Warwick
    Bell, Sally J.
    Brown, Steven J.
    Connell, William R.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (06): : 653 - 661
  • [6] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [7] Editorial: proactive anti-TNF drug monitoring in IBD-Ready for prime time?
    Roblin, Xavier
    Nancey, Stephane
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1453 - 1454
  • [8] Proactive therapeutic drug monitoring of anti-TNF agents is associated with higher mucosal healing rates in Crohn's disease
    Brinar, M.
    Sabic, M.
    Turk, N.
    Grgic, D.
    Domislovic, V.
    Cavka, S. Cukovic
    Kozmar, A.
    Krznaric, Z.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S506 - S506
  • [9] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 149 - 149
  • [10] A UK NATIONAL SURVEY OF THERAPEUTIC DRUG MONITORING WITH ANTI-TNF MEDICATIONS IN IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav
    Kontopantelis, Evan
    Hayee, Bu
    Limdi, Jimmy
    GUT, 2019, 68 : A86 - A87
12345